The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...
High-dose treatment with the therapy was found to cause a 3.3% overall improvement in left ventricular ejection fraction.
Shares of Cumberland Pharmaceuticals continued their eye-opening ascent Wednesday on heavy volume.
Cumberland Pharmaceuticals saw its shares pop Tuesday, finishing the trading day up 76 percent on heavy volume following ...
After hours: February 7 at 7:59:04 PM EST Loading Chart for CPIX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback